SP
Steve Paul
Development and Chief Scientific Officer at Karuna Therapeutics
United States
Overview
Steve Paul is the President of Research & Development and Chief Scientific Officer at Karuna Therapeutics, Inc, with a background in biotechnology and clinical research. He has held leadership roles at various biotech companies, including CEO and Chairman of the Board at Karuna Therapeutics, Inc, and CEO at Voyager Therapeutics, Inc. Steve has invested in several successful companies, such as Rapport Therapeutics, SAGE Therapeutics, and Voyager Therapeutics.
Work Experience
President of Research & Development and Chief Scientific Officer
2023 - Current
Karuna Therapeutics is a biopharmaceutical company that develops and delivers medicines for psychiatric and neurological conditions.
Raised $1,598,600,000.00 from PureTech Health, Alexandria Venture Investments, Partner Fund Management, Fidelity, Sands Capital Ventures, Wellcome Trust, Eventide, ARCH Venture Partners, Pivotal bioVenture Partners and Sofinnova Investments.
CEO and Chairman of the Board
2018
Senior Advisor, Co-founder and Board Member
2018
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Raised $374,000,000.00 from Neurocrine Biosciences.
CEO
2014 - 2018
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Raised $374,000,000.00 from Neurocrine Biosciences.